Unigestion Holding Sa Merck & Co., Inc. Transaction History

Unigestion Holding Sa

$1.68 Billion
Q1 2025

A detailed history of Unigestion Holding Sa transactions in Merck & Co., Inc. stock. As of the latest transaction made, Unigestion Holding Sa holds 54,996 shares of MRK stock, worth $4.73 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

54,996

Previous 24,218 127.09%

Holding current value

$4.73 Million

Previous $2.41 Million 104.9%

% of portfolio

0.29%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$83.01 - $101.02 $2.55 Million - $3.11 Million	30,778 Added 127.09%	54,996 $4.94 Million
Q4 2024 Feb 13, 2025	SELL	$96.31 - $114.76 $3.33 Million - $3.97 Million	-34,567 Reduced 58.8%	24,218 $2.41 Million
Q3 2024 Nov 19, 2024	SELL	$111.15 - $128.97 $36.8 Million - $42.7 Million	-330,882 Reduced 84.91%	58,785 $6.68 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $17.1 Million - $18.4 Million	138,091 Added 54.89%	389,667 $48.2 Million
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $15.6 Million - $18.2 Million	-138,091 Reduced 35.44%	251,576 $33.2 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $9.56 Million - $10.4 Million	-95,444 Reduced 19.67%	389,667 $42.5 Million
Q3 2023 Oct 31, 2023	SELL	$102.95 - $114.33 $559,018 - $620,811	-5,430 Reduced 1.11%	485,111 $49.9 Million
Q2 2023 Jul 27, 2023	SELL	$108.61 - $118.38 $6.24 Million - $6.81 Million	-57,493 Reduced 10.49%	490,541 $56.6 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $3.53 Million - $3.94 Million	-34,282 Reduced 5.89%	548,034 $58.3 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $1.24 Million - $1.6 Million	-14,235 Reduced 2.39%	582,316 $64.6 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $11.8 Million - $13.2 Million	139,416 Added 30.5%	596,551 $51.7 Million
Q2 2022 Aug 03, 2022	BUY	$83.49 - $94.64 $12.6 Million - $14.3 Million	150,959 Added 49.3%	457,135 $41.7 Million
Q1 2022 Apr 14, 2022	BUY	$73.51 - $82.4 $10.7 Million - $12 Million	145,881 Added 91.01%	306,176 $25.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $3.15 Million - $3.94 Million	43,530 Added 37.28%	160,295 $12.3 Million
Q3 2021 Oct 14, 2021	SELL	$71.68 - $78.83 $327,577 - $360,253	-4,570 Reduced 3.77%	116,765 $8.77 Million
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $15.9 Million - $17.6 Million	-226,665 Reduced 65.13%	121,335 $9.37 Million
Q1 2021 May 05, 2021	SELL	$68.86 - $81.11 $27.5 Million - $32.4 Million	-399,149 Reduced 53.42%	348,000 $26.8 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $2.08 Million - $2.31 Million	-29,030 Reduced 3.74%	747,149 $61.1 Million
Q3 2020 Nov 10, 2020	SELL	$73.18 - $82.95 $22.7 Million - $25.8 Million	-310,730 Reduced 28.59%	776,179 $64.3 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $10.7 Million - $12.1 Million	151,382 Added 16.18%	1,086,909 $84 Million
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $49 Million - $67.9 Million	772,936 Added 475.39%	935,527 $72 Million
Q3 2019 Nov 04, 2019	BUY	$76.08 - $82.93 $964,618 - $1.05 Million	12,679 Added 8.46%	162,591 $13.7 Million
Q2 2019 Jul 15, 2019	BUY	$69.84 - $81.59 $1.07 Million - $1.25 Million	15,371 Added 11.42%	149,912 $12.6 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $11.4 Million - $13.1 Million	-164,557 Reduced 55.02%	134,541 $11.2 Million
Q4 2018 Feb 08, 2019	SELL	$65.24 - $75.71 $10.6 Million - $12.3 Million	-162,942 Reduced 35.27%	299,098 $22.9 Million
Q3 2018 Nov 05, 2018	SELL	$57.69 - $67.84 $686,337 - $807,092	-11,897 Reduced 2.51%	462,040 $32.8 Million
Q2 2018 Jul 24, 2018	BUY	$50.83 - $59.72 $24.1 Million - $28.3 Million	473,937 New	473,937 $28.8 Million

Others Institutions Holding MRK

# of Institutions

3,859

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

29.9M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $218B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Unigestion Holding Sa with notifications on news.

Account

Unigestion Holding Sa Merck & Co., Inc. Transaction History